Little Green Pharma Ltd (ASX: LGP, “LGP” or the “Company”) is pleased to announce that it has shipped its first batch of LGP-branded high-THC Desert Flame cannabis flower products to Poland.
The shipment is the culmination of an over three-year process which included obtaining a Polish Marketing Authorisation from the Polish health regulator, with the products to be distributed in Poland by LGP’s distribution partner, Medezin. See ASX announcement dated 2 August 2023 for further details in relation to LGP’s Polish market engagement: Desert-Flame-granted-Polish-Marketing-Authorisation.pdf (investlittlegreenpharma.com)
The Polish cannabis market is currently serviced by less than 10 suppliers, predominantly large North American suppliers such as Curaleaf, Aurora, Canopy Growth and Tilray, with LGP being the first Australian company in market. With a population of 38 million, an import only supply regime, general practitioner prescribing capability, no restrictions on the conditions treatable with cannabis, and a predicted compound annual growth rate (CAGR) of 16%1, LGP regards Poland as a highly prospective new medicinal cannabis market in Europe alongside France and Italy.
Contact details:
David Tasker
M: +61 433 112 936
E: dtasker@chapteroneadvisors.com.au
